Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
nuclivision from Gent, company number BE0786830643, closed financial year 2025 with a result of € -408,349 after tax. For that financial year nuclivision recorded a gross margin of € -14,470 and equity of € 1.9 million. Compared with financial year 2024, the result moved from € -140,654 to € -408,349. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ 1.9 million
▲ € 2.1 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -408,349
▼ 190 % more loss than in 2024
Profit after tax over the fiscal year.
€ 200,463
▲ 210% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -710,046.
People and assets in 2025
€ 289,285
▲ 21% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 37,411
▼ 51% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 95,029
▲ 261% vs 2024
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 119,826 | € 173,738 | € -14,470 | ▼ € 188,207 |
| Profit after taxes | € -161,043 | € -140,654 | € -408,349 | ▼ € 267,694 |
| Equity | € -81,061 | € -221,716 | € 1,861,862 | ▲ € 2.1 million |
| Total debts | € 458,863 | € 566,172 | € 133,289 | ▼ 76% |
| Cash | € 152,779 | € 64,577 | € 200,463 | ▲ 210% |
| Retained profit | € -161,043 | € -301,697 | € -710,046 | ▼ € 408,349 |
| Bank debt | € 371,000 | € 408,500 | € 0 | ▼ 100% |
| Balance sheet total | € 377,802 | € 344,457 | € 1,995,151 | ▲ € 1.7 million |
Key figures of nuclivision, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to nuclivision?
What happened at nuclivision in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 408,349. Source: NBB ↗
- Gabriel Paul Krestin became a director. NBB
- SUIIUS BV became a director. NBB
- Heran Partners BV became a director. NBB
- Maarten Larmuseau became a director. NBB
- Lumo Labs BV became a director. NBB
- Tomas Brants became a director. NBB
- New establishment in Gent. KBO
In short
From € 161,043 loss in 2023 to € 408,349 loss in 2025.
Paid € 3,631 in corporate taxes since 2023.
Management
The stake of Heran HealthTech Fund I, LUMIARES comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
nuclivisionBehind nuclivision are SUIIUS BV, Gabriel Paul Krestin, Heran Partners BV, Maarten Larmuseau, Lumo Labs BV and Tomas Brants. The shares are held by Heran HealthTech Fund I (15.1%) and LUMIARES (10%).
Directors
According to the 2025 annual accounts
Director · represented by Vandenberk Kris
since 2025
Gabriel Paul Krestin
Director
since 2026
Director · represented by Verrelst Herman
Also active at: Lynxcare Clinical Informatics, FOx Biosystems, ASPECT ANALYTICS, Heran HealthTech Fund I, ImmuneSpec, AMARON, icometrix, ONTOFORCE
since 2025
Maarten Larmuseau
Director
since 2025
Lumo Labs BV
Director · represented by Hannes Thomas
since 2025
Tomas Brants
Director
since 2025
Shareholders
15.1%
10%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Edward Pynaertkaai 87
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0786.830.643
- VAT number
- BE 0786.830.643
- Registered office
- Edward Pynaertkaai 87, 9000 Gent
- Names & denominations
- nuclivision
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 June 2022
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten van medisch specialisten
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied